Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

THC:CBD 1:1

Phase 1Small molecule

WWayne State University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

MarijuanaNot yet recruiting

MarijuanaPhase 1

Not yet recruiting

Timeline

Expected Milestones

Q3 2031

Phase 1Not yet recruiting

Marijuana

NCT06222268

Clinical

Trials by Indication[1]

Marijuana1 trial

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery

Not yet recruiting·WWayne State University·Phase 1·NCT06222268·280 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for THC:CBD 1:1. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — THC:CBD 1:1 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for THC:CBD 1:1. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Wayne State University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: WWayne State University

Related News